Breast Neoplasms

"Breast Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the human BREAST.

Descriptor ID	D001943
MeSH Number(s)	C04.588.180 C17.800.090.500
Concept/Terms	Breast Neoplasms Breast Neoplasms Breast Neoplasm Neoplasm, Breast Breast Tumors Breast Tumor Tumor, Breast Tumors, Breast Neoplasms, Breast Breast Carcinoma Breast Carcinoma Breast Carcinomas Carcinoma, Breast Carcinomas, Breast Mammary Neoplasms, Human Mammary Neoplasms, Human Human Mammary Neoplasm Human Mammary Neoplasms Neoplasm, Human Mammary Neoplasms, Human Mammary Mammary Neoplasm, Human Breast Cancer Breast Cancer Cancer, Breast Mammary Cancer Cancer, Mammary Cancers, Mammary Mammary Cancers Malignant Neoplasm of Breast Breast Malignant Neoplasm Breast Malignant Neoplasms Malignant Tumor of Breast Breast Malignant Tumor Breast Malignant Tumors Cancer of Breast Cancer of the Breast

Below are MeSH descriptors whose meaning is more general than "Breast Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Breast Neoplasms [C04.588.180]
Skin and Connective Tissue Diseases [C17]
Skin Diseases [C17.800]
Breast Diseases [C17.800.090]
Breast Neoplasms [C17.800.090.500]

Below are MeSH descriptors whose meaning is more specific than "Breast Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Breast Neoplasms" by people in this website by year, and whether "Breast Neoplasms" was a major or minor topic of these publications.

Bar chart showing 1117 publications over 30 distinct years, with a maximum of 72 publications in 2015

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	2	0	2
1996	4	2	6
1997	7	0	7
1998	7	2	9
1999	5	2	7
2000	0	2	2
2001	7	2	9
2002	24	6	30
2003	25	7	32
2004	26	6	32
2005	39	6	45
2006	37	8	45
2007	39	6	45
2008	40	6	46
2009	30	6	36
2010	42	10	52
2011	57	11	68
2012	55	9	64
2013	61	6	67
2014	52	6	58
2015	64	8	72
2016	44	4	48
2017	52	2	54
2018	31	5	36
2019	49	0	49
2020	45	1	46
2021	37	2	39
2022	49	1	50
2023	39	0	39
2024	21	1	22

Below are the most recent publications written about "Breast Neoplasms" by people in Profiles.

Debeljak M, Cho S, Downs BM, Considine M, Avin-McKelvey B, Wang Y, Perez PN, Grizzle WE, Hoadley KA, Lynch CF, Hernandez BY, van Diest PJ, Cozen W, Hamilton AS, Hawes D, Gabrielson E, Cimino-Mathews A, Florea LD, Cope L, Umbricht CB. Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ. Breast Cancer Res. 2024 Dec 04; 26(1):178.

View in: PubMed
Dunn MR, Li D, Emerson MA, Thompson CA, Nichols HB, Van Alsten SC, Roberson ML, Wheeler SB, Carey LA, Hyslop T, Elston Lafata J, Troester MA. A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness. PLoS Med. 2024 Dec; 21(12):e1004500.

View in: PubMed
Aguilar-Garc?a XJ, Luna-Alvear AE, Narv?ez-Bandera I, Su?rez-G?mez D, Isaza CE, Cabrera-Rios M. Breast and Colorectal Cancers in Women: a Meta-Analysis Driven by BioOptimatics. P R Health Sci J. 2024 Dec; 43(4):186-195.

View in: PubMed
Campbell MJ, Wolf DM, Yau C, Brown-Swigart L, Wulfkuhle J, Gallagher IR, Zhu Z, Bolen J, Vandenberg S, Hoyt C, Mori H, Borowsky A, Sit L, Perlmutter J, Asare SM, Nanda R, Liu MC, Yee D, DeMichele AM, Hylton NM, Pusztai L, Berry DA, Hirst GL, Petricoin EF, Veer LV, Esserman L. Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer. Cell Rep Med. 2024 Nov 19; 5(11):101799.

View in: PubMed
Son DS, Adunyah SE. Roles of Chemokine Axes in Breast Cancer. Front Biosci (Landmark Ed). 2024 Oct 18; 29(10):358.

View in: PubMed
Varriano S, Yu A, Xu YQ, Natelson DM, Ramadei A, Kleiman FE. Estrogen receptor alpha (ERa) regulates PARN-mediated nuclear deadenylation and gene expression in breast cancer cells. RNA Biol. 2024 01; 21(1):14-23.

View in: PubMed
Abe JV, Legaspi J, Guillermo C, Bogumil D, Setiawan VW, Le Marchand L, Hernandez BY, Wilkens LR, Maskarinec G. Breast, Colorectal, and Prostate Cancer Incidence among Filipino Americans by Generational Status in the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev. 2024 Oct 02; 33(10):1311-1317.

View in: PubMed
O'Driscoll J, Burton A, Maskarinec G, Perez-Gomez B, Vachon C, Miao H, Lajous M, L?pez-Ridaura R, Eliassen AH, Pereira A, Garmendia ML, Tamimi RM, Bertrand K, Kwong A, Ursin G, Lee E, Qureshi SA, Ma H, Vinnicombe S, Moss S, Allen S, Ndumia R, Vinayak S, Teo SH, Mariapun S, Fadzli F, Peplonska B, Nagata C, Stone J, Hopper JL, Giles G, Ozmen V, Aribal ME, Sch?z J, Van Gils CH, Wanders JOP, Sirous R, Sirous M, Hipwell J, Kim J, Lee JW, Hartman M, Li J, Scott C, Chiarelli AM, Linton L, Pollan M, Flugelman AA, Salem D, Kamal R, Boyd N, Dos-Santos-Silva I, McCormack V, Mullooly M. Reproductive factors and mammographic density within the International Consortium of Mammographic Density: A cross-sectional study. Breast Cancer Res. 2024 Sep 30; 26(1):139.

View in: PubMed
Tecchio KB, Alves FM, Alves JD, Barbosa CS, Salgado MAR, Santos VJDSVD, Varotti FP, Campos-Junior PHA, Viana GHR, Santos FVD. Evaluation of the in vivo acute toxicity and in vitro genotoxicity and mutagenicity of synthetic ?-carboline alkaloids with selective cytotoxic activity against ovarian and breast cancer cell lines. Mutat Res Genet Toxicol Environ Mutagen. 2024 Oct; 899:503808.

View in: PubMed
Sun X, Verma SP, Jia G, Wang X, Ping J, Guo X, Shu XO, Chen J, Derkach A, Cai Q, Liang X, Long J, Offit K, Oh JH, Reiner AS, Watt GP, Woods M, Yang Y, Ambrosone CB, Ambs S, Chen Y, Concannon P, Garcia-Closas M, Gu J, Haiman CA, Hu JJ, Huo D, John EM, Knight JA, Li CI, Lynch CF, Mellemkj?r L, Nathanson KL, Nemesure B, Olopade OI, Olshan AF, Pal T, Palmer JR, Press MF, Sanderson M, Sandler DP, Troester MA, Zheng W, Bernstein JL, Buas MF, Shu X. Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants That Confer Risk for Breast Cancer. Cancer Res. 2024 Aug 01; 84(15):2533-2548.

View in: PubMed

People

Explore

Similar Concepts

Top Journals